Eco-evolutionary causes and consequences of temporal changes in intratumoural blood flow

RJ Gillies, JS Brown, ARA Anderson… - Nature Reviews …, 2018 - nature.com
Temporal changes in blood flow are commonly observed in malignant tumours, but the
evolutionary causes and consequences are rarely considered. We propose that stochastic …

Using chronobiology-based second-generation artificial intelligence digital system for overcoming antimicrobial drug resistance in chronic infections

Y Kolben, H Azmanov, R Gelman, D Dror… - Annals of Medicine, 2023 - Taylor & Francis
Antimicrobial resistance results from the widespread use of antimicrobial agents and is a
significant obstacle to the effectiveness of these agents. Numerous methods are used to …

Spatial heterogeneity and evolutionary dynamics modulate time to recurrence in continuous and adaptive cancer therapies

JA Gallaher, PM Enriquez-Navas, KA Luddy… - Cancer research, 2018 - AACR
Abstract Treatment of advanced cancers has benefited from new agents that supplement or
bypass conventional therapies. However, even effective therapies fail as cancer cells deploy …

Exploiting evolutionary steering to induce collateral drug sensitivity in cancer

A Acar, D Nichol, J Fernandez-Mateos… - Nature …, 2020 - nature.com
Drug resistance mediated by clonal evolution is arguably the biggest problem in cancer
therapy today. However, evolving resistance to one drug may come at a cost of decreased …

Phenotypic heterogeneity in human genetic diseases: ultrasensitivity-mediated threshold effects as a unifying molecular mechanism

YH Sun, YL Wu, BY Liao - Journal of Biomedical Science, 2023 - Springer
Phenotypic heterogeneity is very common in genetic systems and in human diseases and
has important consequences for disease diagnosis and treatment. In addition to the many …

Collateral sensitivity networks reveal evolutionary instability and novel treatment strategies in ALK mutated non-small cell lung cancer

A Dhawan, D Nichol, F Kinose, ME Abazeed… - Scientific reports, 2017 - nature.com
Drug resistance remains an elusive problem in cancer therapy, particularly for novel
targeted therapies. Much work is focused upon the development of an arsenal of targeted …

Understanding the role of phenotypic switching in cancer drug resistance

EB Gunnarsson, S De, K Leder, J Foo - Journal of theoretical biology, 2020 - Elsevier
The emergence of acquired drug resistance in cancer represents a major barrier to
treatment success. While research has traditionally focused on genetic sources of …

Cross-resistance among sequential cancer therapeutics: an emerging issue

R Loria, P Vici, FS Di Lisa, S Soddu… - Frontiers in …, 2022 - frontiersin.org
Over the past two decades, cancer treatment has benefited from having a significant
increase in the number of targeted drugs approved by the United States Food and Drug …

Multivalent state transitions shape the intratumoral composition of small cell lung carcinoma

P Gopal, A Petty, K Rogacki, T Bera, R Bareja… - Science …, 2022 - science.org
Studies to date have not resolved how diverse transcriptional programs contribute to the
intratumoral heterogeneity of small cell lung carcinoma (SCLC), an aggressive tumor …

Antifragility in complex dynamical systems

C Axenie, O López-Corona, MA Makridis… - npj Complexity, 2024 - nature.com
Antifragility characterizes the benefit of a dynamical system derived from the variability in
environmental perturbations. Antifragility carries a precise definition that quantifies a …